Abstract
Chronic obstructive pulmonary disease (COPD) is one of the most popular respiratory diseases among the world.Due to the unclear pathogenesis of COPD,the current treatment direction is mostly to prevent and relieve the existing symptoms.The current direction oftreatment for COPD is to control the disease and delay its progression through medication,physical therapy,and surgery in severe cases. Inhaled glucocorticoids,long-acting β agonists (LABA) and long-acting muscarine anticholinergic (LAMA) are widely used in the treatment of COPD.This article discusses the specific symptoms of COPD,and discusses the feasibility and development level of combined therapy combined with the current situation of relevant drug therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
